Safety and Immunogenicity of RTS,S/AS02D Malaria Vaccine in Infants
Authors:
- Salim AbdullaSASalim Abdulla
- Rolf OberholzerRORolf Oberholzer
- Omar JumaOJOmar Juma
- Sulende KubhojaSKSulende Kubhoja
- Francisca MacheraFMFrancisca Machera
- Christopher MembiCMChristopher Membi
- Said OmariSOSaid Omari
- Alwisa UrassaAUAlwisa Urassa
- Hassan MshindaHMHassan Mshinda
- Ajuza JumanneAJAjuza Jumanne
- Nahya SalimNSNahya Salim
- Mwanjaa ShomariMSMwanjaa Shomari
- 11 December 2008
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 359 (24) , 2533-2544
Abstract
The RTS,S/AS malaria vaccine is being developed for delivery through the World Health Organization's Expanded Program on Immunization (EPI). We assessed the feasibility of integrating RTS,S/AS02D into a standard EPI schedule for infants.Keywords
This publication has 10 references indexed in Scilit:
- Did They Really Say ... Eradication?Science, 2007
- Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trialThe Lancet, 2007
- Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trialTrials, 2007
- Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialThe Lancet, 2005
- Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trialThe Lancet, 2004
- Malaria in southern Mozambique: Malariometric indicators and malaria casedefinition in Manhiça districtTransactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trialThe Lancet, 2001
- Efficacy of Recombinant Circumsporozoite Protein Vaccine Regimens against ExperimentalPlasmodium falciparumMalariaThe Journal of Infectious Diseases, 2001
- A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalariaNew England Journal of Medicine, 1997
- Severe childhood malaria in two areas of markedly different falciparum transmission in East AfricaActa Tropica, 1994